GENERAL CATALOGUE
EGFR-IN-139
HY-170438 · 50 mg
MedChemExpress · Cat: HY-170438
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/egfr-in-139.htmlCatalog No: HY-170438
CAS No: 1574321-31-5
Category: JAK STAT Signaling
Pack Size: 50 mg
Brand: MedChemExpress
Description
EGFR-IN-139 compound PD 18 is an epidermal growth factor receptor EGFR inhibitor, with IC50s of 12.88 wild type , 10.84 L858R/T790M , 42.68 L858R/T790M/C797S nM, respectively. EGFR-IN-139 displays strong anticancer activity against A549 and H1975 cancer cell lines, which are highly expressed EGFR. EGFR-IN-139 has a strong selectivity to cancer cells. EGFR-IN-139 can be used for nonsmall cell lung cancer NSCLC research 1 .
More from MedChemExpress
STAT6-IN-2
HY-153991
JAK STAT Signaling
EGFR-IN-115
HY-162602
JAK STAT Signaling
ErbB-2-binding peptide
HY-P4082
JAK STAT Signaling
TX2-121-1
HY-118998
JAK STAT Signaling
AZ7550
HY-B0794
JAK STAT Signaling
EGFR-IN-38
HY-144055
JAK STAT Signaling
CCT365623 hydrochloride
HY-124674A
JAK STAT Signaling
HER2-IN-20
HY-163657
JAK STAT Signaling